Condor Pharma Logo
Making AI Work for Life Sciences
Pharma | biotech | medical devices

Making AI work for life sciences

Condor Pharma helps regulated teams adopt AI with confidence: practical strategy, implementation support, and governance that stands up to regulatory scrutiny.

From discovery to quality, regulatory, and operations, AI is now a core capability for modern life sciences organisations. The challenge is to operationalise AI safely in a highly regulated environment.

We work with organisations that need progress without unnecessary risk: clearer use-case selection, better governance foundations, and implementation approaches that are designed for accountability from day one.

We are also building our own software solutions for many of the governance challenges we see in the industry.

Flask illustration for AI education in life sciences
50% *
reduction in preclinical development timelines reported by AI-enabled pharma organisations
$70bn **
projected value AI could add to the pharmaceutical industry by 2030 through R&D and operational efficiency
>56K ***
J&J employees trained on AI before authorised deployment — a template the industry is following
Register See Capabilities

* McKinsey — AI in Drug Discovery  |  ** Evaluate Vantage — AI Investment in Pharma  |  *** Business Insider (March 2025)

AI Strategy & Delivery
Governance by Design
MHRA Aligned
EMA Compliant
FDA Ready
Regulatory-Grade Auditability
The Opportunity

A strategic shift — and a chance to lead

Life sciences is entering a phase where AI adoption has to be both ambitious and controlled. Condor Pharma supports that balance by helping organisations move quickly where value is clear while building governance that can stand up to inspection and internal challenge.

The direction of travel is clear. Expectations from MHRA, EMA, and FDA continue to evolve around explainability, accountability, data integrity, and oversight of AI-enabled processes. Teams that build these capabilities now can innovate decisively instead of reacting under pressure later.

The opportunity is not simply to "use AI" but to turn AI into a reliable, regulated business capability across functions.

🔬

AI Strategy with Regulatory Context

Define where AI can add measurable value first, then sequence delivery so each use case aligns with quality, clinical, and regulatory expectations from the outset.

📋

Governance by Design

Embed controls, ownership, and evidence trails into AI workflows early, so innovation is auditable and defensible rather than dependent on manual remediation later.

🏭

Cross-Functional Enablement

Bridge leadership, quality, regulatory, technical and operational teams around a shared AI operating model so adoption scales consistently across the organisation.

💊

LifeGuard in Development

Our upcoming LifeGuard middleware is being designed to screen every AI interaction against regulatory and domain-specific rules, with tamper-evident traceability built for high-scrutiny environments.

Capabilities

AI Innovation Services for Life Sciences

Condor Pharma combines practical AI expertise with life sciences regulatory understanding to help organisations move from pilots to dependable, governed deployment.

  • ✓
    AI opportunity mapping — identify high-impact use cases with realistic implementation pathways and clear ownership
  • ✓
    Regulatory-aligned implementation design — shape solutions around domain constraints rather than retrofitting compliance later
  • ✓
    AI governance framework support — establish policies, review checkpoints, risk controls, and accountability across teams
  • ✓
    Evidence-ready workflow design — structure records and decisions so AI usage is transparent and inspection-ready
  • ✓
    Technical translation for leadership teams — turn AI complexity into clear business and risk decisions
  • ✓
    Cross-jurisdiction perspective — practical alignment to UK, EU and US regulatory direction where relevant
  • ✓
    Advisory and delivery collaboration — support from early framing through implementation planning
  • ✓
    LifeGuard roadmap integration — prepare now for policy-aware AI middleware as it progresses through development
Focus Areas

Where we help life sciences teams move faster

Our work spans strategy, delivery design, and governance support across the functions where AI creates value and scrutiny at the same time.

🧠

AI Strategy & Prioritisation

Define the use cases worth pursuing, map expected impact, and sequence initiatives so teams deliver measurable value without overextending governance capacity.

Leadership and programme owners
🏭

Quality & GxP Operations

Support AI-enabled workflows in GMP and quality systems with governance, data integrity principles, and clear oversight boundaries for critical decisions.

QA and operations functions
📄

Regulatory & Compliance

Design AI usage patterns and evidence models that align with evolving expectations from MHRA, EMA, and FDA around accountability and defensibility.

Regulatory and compliance leaders
💊

Clinical & Safety Functions

Enable responsible AI usage in clinical and safety-critical workflows where consistency, traceability, and human oversight remain non-negotiable.

Clinical, PV and medical teams
🎨

Technical Delivery Oversight

Bridge business intent and technical implementation so AI solutions are not only functional, but monitorable, maintainable, and compatible with internal controls.

Product and technical teams
🔬

LifeGuard

In development: Life Sciences-grade middleware that screens every AI interaction against regulatory and domain-specific rules, with a tamper-evident audit trail built for regulatory scrutiny.

In development
How We Work

Practical collaboration from concept to controlled rollout

We work as a partner to life sciences teams: shaping strategy, de-risking implementation, and helping establish controls that keep innovation moving under real-world regulatory pressure.

For Leadership Teams

Direction, governance, and measurable progress

Align AI priorities to business outcomes, assign clear ownership, and build governance that scales with adoption across departments.

For Delivery Teams

Implementation support with regulatory awareness

Move AI initiatives into operation with practical design choices, risk controls, and evidence models that can withstand internal and external scrutiny.

For Regulatory & Quality Teams

AI usage patterns and evidence models

Design AI usage patterns and evidence models that align with evolving expectations from MHRA, EMA, and FDA around accountability and defensibility.

For IT Teams

Governance by design

Embed controls, ownership, and evidence trails into AI workflows early, so innovation is auditable and defensible rather than dependent on manual remediation later.

Why Trust Us
Condor Pharma Logo
Making AI Work for Life Sciences

Life sciences depth with real AI delivery experience

Condor Pharma sits at the intersection of life sciences operations, regulatory expectations, and modern AI implementation.

Our team has worked alongside pharmaceutical and medical device organisations across development, quality, manufacturing, and regulatory activities. We understand the practical realities of GxP environments, not just the theory.

That domain grounding is combined with hands-on software and AI experience, allowing us to help clients translate AI ambition into robust, governed operating models.

We are also developing LifeGuard to address a recurring gap we see in the market: policy-aware AI middleware with tamper-evident auditability designed specifically for regulatory scrutiny in life sciences.

Regulatory Reality

Deep life sciences experience across medicines and devices, including practical understanding of MHRA, EMA, GxP, and inspection expectations.

Technical Accuracy

AI and software expertise grounded in delivery reality, helping teams move beyond theory into practical and controllable implementation.

Sector Specific

Sector-specific perspective tailored to life sciences contexts, where innovation, patient safety, and compliance obligations must coexist.

Combined Expertise

Combined technical and regulatory fluency to design AI operating approaches that are effective in practice and credible under scrutiny.

In Development

LifeGuard

LifeGuard is currently in development as a core Condor Pharma product for high-trust AI deployment in regulated environments.

What It Is

Policy-Aware AI Control Layer
Designed for regulated life sciences use
✓Life Sciences-grade middleware
✓Screens every AI interaction
✓Regulatory and domain rule enforcement
✓Tamper-evident audit trail
Discuss Early Access

Why It Matters

Built for Regulatory Scrutiny
From day one, not as an afterthought
✓Supports consistent AI governance
✓Improves traceability and accountability
✓Reduces manual control burden
✓Designed to integrate with operational workflows
Talk to Condor
LifeGuard Vision — "Life Sciences-grade middleware that screens every AI interaction against regulatory and domain-specific rules, with a tamper-evident audit trail built for regulatory scrutiny."
Enquire About LifeGuard
Frequently Asked Questions

Common questions we get asked:

What does Condor Pharma do?

We help life sciences organisations adopt AI as a dependable business capability, combining strategic guidance, implementation support, and governance-focused design tailored to regulated environments. We also develop our own software solutions for many of the governance challenges we see in the industry.

What is LifeGuard?

LifeGuard is our product currently in development: Life Sciences-grade middleware that screens every AI interaction against regulatory and domain-specific rules, with a tamper-evident audit trail built for regulatory scrutiny.

Is LifeGuard available today?

LifeGuard is in active development. We are discussing early collaboration with organisations that want to shape requirements and prepare for adoption in high-scrutiny environments.

How does Condor approach evolving regulation?

We work from sound regulatory and software development principles and practical evidence expectations, helping teams design AI operating approaches that are explainable, controlled, and auditable as guidance continues to evolve.

Who is this relevant for?

Pharmaceutical, biotech, and medical device organisations seeking to scale AI responsibly across quality, regulatory, clinical, operations, and technical functions.

Ready to build AI capability with confidence?

Whether you are shaping your AI roadmap or exploring LifeGuard, we would be glad to discuss your goals. Send us an email at and we will be in touch.

Contact Condor